We enclose a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company for Carboprost Tromethamine Injection USP 250 mcg/mL.
26-May-2023
Download PDF
Aurobindo Pharma
We enclose a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company for Carboprost Tromethamine Injection USP 250 mcg/mL.
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month